tiprankstipranks
MannKind Corporation (CH:NNFN)
NASDAQ:NNFN
Switzerland Market
NNFN
MannKind
RESEARCH TOOLSreports

MannKind (NNFN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

NNFN Analyst Ratings

Strong Buy
6Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
Based on 6 analysts giving stock ratings to
MannKind
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NNFN Stock 12 Month Forecast

Average Price Target

$6.55
Based on 6 Wall Street analysts offering 12 month price targets for MannKind in the last 3 months. The average price target is $6.55 with a high forecast of $8.85 and a low forecast of $3.82. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$8.85Average Price Target$6.55Lowest Price Target$3.82
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:NNFN
Benjamin Burnett
Wells Fargo
Wells Fargo
CHF8.85
Buy
―
Reiterated
06/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on CH:NNFN
Gregory Renza
Truist Financial
Truist Financial
―
Buy
―
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright Analyst forecast on CH:NNFN
Brandon Folkes
H.C. Wainwright
H.C. Wainwright
CHF8.04
Buy
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD) and Option Care Health (NASDAQ: OPCH)
Wedbush Analyst forecast on CH:NNFN
Yun Zhong
Wedbush
Wedbush
CHF6.43
Buy
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), BioNTech SE (NASDAQ: BNTX) and Pfizer (NYSE: PFE)
Mizuho Securities Analyst forecast on CH:NNFN
Anthony Petrone
Mizuho Securities
Mizuho Securities
CHF6.43→CHF5.63
Buy
―
Reiterated
05/07/26
MannKind price target lowered to $7 from $8 at MizuhoMannKind price target lowered to $7 from $8 at Mizuho
RBC Capital Analyst forecast on CH:NNFN
Douglas Miehm
RBC Capital
RBC Capital
CHF2.81→CHF3.82
Hold
―
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (NASDAQ: ONC), United Therapeutics (NASDAQ: UTHR) and MannKind (NASDAQ: MNKD)
Raymond James Analyst forecast on CH:NNFN
Tiago Fauth
Raymond James
Raymond James
CHF6.43→CHF5.63
Buy
―
Reiterated
02/27/26
MannKind price target lowered to $7 from $8 at Wells FargoMannKind price target lowered to $7 from $8 at Wells Fargo
Leerink Partners Analyst forecast on CH:NNFN
Roanna Ruiz
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (NASDAQ: MDLN) and MannKind (NASDAQ: MNKD)
Jefferies Analyst forecast on CH:NNFN
Faisal Khurshid
Jefferies
Jefferies
CHF7.24
Buy
―
Initiated
10/10/25
MannKind (MNKD) Receives a Buy from Leerink Partners
William Blair Analyst forecast on CH:NNFN
Steven Lichtman
William Blair
William Blair
CHF9.65→CHF12.06
Buy
―
Reiterated
09/05/25
MannKind price target raised to $15 from $12 at OppenheimerMannKind price target raised to $15 from $12 at Oppenheimer
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:NNFN
Benjamin Burnett
Wells Fargo
Wells Fargo
CHF8.85
Buy
―
Reiterated
06/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on CH:NNFN
Gregory Renza
Truist Financial
Truist Financial
―
Buy
―
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright Analyst forecast on CH:NNFN
Brandon Folkes
H.C. Wainwright
H.C. Wainwright
CHF8.04
Buy
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD) and Option Care Health (NASDAQ: OPCH)
Wedbush Analyst forecast on CH:NNFN
Yun Zhong
Wedbush
Wedbush
CHF6.43
Buy
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), BioNTech SE (NASDAQ: BNTX) and Pfizer (NYSE: PFE)
Mizuho Securities Analyst forecast on CH:NNFN
Anthony Petrone
Mizuho Securities
Mizuho Securities
CHF6.43→CHF5.63
Buy
―
Reiterated
05/07/26
MannKind price target lowered to $7 from $8 at MizuhoMannKind price target lowered to $7 from $8 at Mizuho
RBC Capital Analyst forecast on CH:NNFN
Douglas Miehm
RBC Capital
RBC Capital
CHF2.81→CHF3.82
Hold
―
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (NASDAQ: ONC), United Therapeutics (NASDAQ: UTHR) and MannKind (NASDAQ: MNKD)
Raymond James Analyst forecast on CH:NNFN
Tiago Fauth
Raymond James
Raymond James
CHF6.43→CHF5.63
Buy
―
Reiterated
02/27/26
MannKind price target lowered to $7 from $8 at Wells FargoMannKind price target lowered to $7 from $8 at Wells Fargo
Leerink Partners Analyst forecast on CH:NNFN
Roanna Ruiz
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (NASDAQ: MDLN) and MannKind (NASDAQ: MNKD)
Jefferies Analyst forecast on CH:NNFN
Faisal Khurshid
Jefferies
Jefferies
CHF7.24
Buy
―
Initiated
10/10/25
MannKind (MNKD) Receives a Buy from Leerink Partners
William Blair Analyst forecast on CH:NNFN
Steven Lichtman
William Blair
William Blair
CHF9.65→CHF12.06
Buy
―
Reiterated
09/05/25
MannKind price target raised to $15 from $12 at OppenheimerMannKind price target raised to $15 from $12 at Oppenheimer
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MannKind

3 Months
Steven LichtmanWilliam Blair
Success Rate
14/19 ratings generated profit
74%
Average Return
+22.15%
Copying Steven Lichtman's trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +22.15% per trade.
1 Year
Steven LichtmanWilliam Blair
Success Rate
13/19 ratings generated profit
68%
Average Return
+69.33%
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +69.33% per trade.
2 Years
Steven LichtmanWilliam Blair
Success Rate
14/19 ratings generated profit
74%
Average Return
+52.50%
Copying Steven Lichtman's trades and holding each position for 2 Years would result in 73.68% of your transactions generating a profit, with an average return of +52.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NNFN Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
9
10
11
13
10
Buy
4
2
1
1
1
Hold
1
3
3
3
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
15
15
17
12
In the current month, NNFN has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NNFN average Analyst price target in the past 3 months is 6.55.
Each month's total comprises the sum of three months' worth of ratings.

NNFN Financial Forecast

NNFN Earnings Forecast

Next quarter’s earnings estimate for NNFN is >-$0.01 with a range of -$0.03 to $0.09. The previous quarter’s EPS was -$0.04. NNFN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.
Next quarter’s earnings estimate for NNFN is >-$0.01 with a range of -$0.03 to $0.09. The previous quarter’s EPS was -$0.04. NNFN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.

NNFN Sales Forecast

Next quarter’s sales forecast for NNFN is $87.80M with a range of $81.63M to $93.69M. The previous quarter’s sales results were $72.51M. NNFN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.
Next quarter’s sales forecast for NNFN is $87.80M with a range of $81.63M to $93.69M. The previous quarter’s sales results were $72.51M. NNFN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.

NNFN Stock Forecast FAQ

What is CH:NNFN’s average 12-month price target, according to analysts?
Based on analyst ratings, MannKind Corporation’s 12-month average price target is 6.55.
    What is CH:NNFN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:NNFN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is MannKind Corporation a Buy, Sell or Hold?
        MannKind Corporation has a consensus rating of Strong Buy, which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
          What is MannKind Corporation’s share price target?
          The average share price target for MannKind Corporation is 6.55. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $8.85 ,and the lowest forecast is $3.82. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about MannKind Corporation?
            MannKind Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of MannKind Corporation?
              To buy shares of CH:NNFN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.